Legend Biotech Corporation Stock News

Related Stocks: PACB , BYND , NTLA , NRIX , NSTG , LSPD , DSGX , LEGN , RKLB , BRKR , ASTR , ACAD , SRAC , MCRB ,

Biopharmaceutical company Legend BioTech (LEGN) hit a new 54-week high this Tuesday, up 103.4% this year.  LEGN is a multinational biopharmaceutical company primarily engaged in the discovery and dev

Legend Biotech's CAR-T therapy's trial results were amazing, and could earn the treatment FDA approval in 2021.

A recent regulatory overhaul designed to speed up development and approval of new drugs in China has been welcomed by global pharma giants and local startups alike, aimed at bringing their latest cutt

Legend Biotech (LEGN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

The stock price of Legend Biotech Corp (NASDAQ: LEGN) increased by over 7% pre-market. This is why it happened.

SOMERSET, N.J.--(BUSINESS WIRE)---- $LEGN #CARTcell--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and developm

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c

Investors need to pay close attention to Legend Biotech (LEGN) stock based on the movements in the options market lately.

The stock price of Legend Biotech Corp (NASDAQ: LEGN) increased by over 10% during intraday trading. This is why it happened.

Genscript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to Genscript's Legend Biotech CAR-T subsidiary. Shanghai Fosun Pharma

The stock price of Legend Biotech Corp (NASDAQ: LEGN) increased by over 10% pre-market. This is why it happened.

SOMERSET, N.J.--(BUSINESS WIRE)---- $LEGN #ASCO21--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and developmen

CANbridge will make a $10 million upfront payment for the two Fabry and Pompe candidates. Guangzhou Link Health Pharma and Australia's George Clinical plan to form a China clinical CRO JV that will co

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c